Wilson Sonsini Goodrich & Rosati advised Fluent Biosciences on the transaction. Illumina, Inc. (NASDAQ: ILMN) announced it has acquired Fluent BioSciences (Fluent), developer of an emerging...
You must be a Standard 1 Year member to access this content.
Cravath, Swaine & Moore represented Illumina, Inc. on the transaction, and Latham & Watkins represented GRAIL, LLC. GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare...
You must be a Standard 1 Year member to access this content.
Cooley advised Illumina, while Budde Schou advised MGI. For years, US biotechnology company Illumina has been litigating in various countries and at the European Patent Office...
You must be a Standard 1 Year member to access this content.
IN BRIEF: BonelliErede, GIM Legal, advised on the matter. BonelliErede advised LendLease with a team including Johannes Karner (Real Estate). GIM Legal advised Illumina Inc with...
You must be a Standard 1 Year member to access this content.
Homburger acted as sole Swiss legal representative of Illumina in this litigation. On November 19, 2021 the Swiss Federal Patent Court handed down a judgment confirming...
You must be a Standard 1 Year member to access this content.
